hotspot -WSS

hotspot

author：hotspot 2025-08-26 23:46:53 - browse：8

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

hotspot

WSS

CRISPR pioneers react to Casgevy, first gene

The problem with charging patients to message their doctors

A daunting task: navigating dual Medicare, Medicaid eligibility

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

IVF, abortion rights issues kick off Biden’s State of the Union

Morphosys mixed study results for blood cancer drug

explore

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

A daunting task: navigating dual Medicare, Medicaid eligibility

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Hepatitis C has a cure — but many Americans still lack access to it

World's first CRISPR

Drug repurposing or repositioning? The language matters

The problem with charging patients to message their doctors

Anesthesiologist group: stop taking Ozempic before surgery

U.K. considers world's first use of meningitis vaccine to address gonorrhea

entertainment

Change Healthcare cyberattack prompts Medicare loan program

In key trial, Verve's treatment lowers cholesterol levels in patients

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Air quality improving but still lags in Black, Hispanic communities

The drug industry has found itself all alone in Washington

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

leisure time

hotspot

explore

leisure time